Sigma Planning Corp Uni Qure N.V. Transaction History

Sigma Planning Corp

$3.22 Billion
Q3 2024

A detailed history of Sigma Planning Corp transactions in Uni Qure N.V. stock. As of the latest transaction made, Sigma Planning Corp holds 48,245 shares of QURE stock, worth $278,856. This represents 0.01% of its overall portfolio holdings.

Number of Shares

48,245

Previous 99,705 51.61%

Holding current value

$278,856

Previous $446,000 46.86%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$3.78 - $10.12 $194,518 - $520,775	-51,460 Reduced 51.61%	48,245 $237,000
Q2 2024 Aug 05, 2024	BUY	$4.39 - $5.43 $74,849 - $92,581	17,050 Added 20.63%	99,705 $446,000
Q1 2024 May 01, 2024	BUY	$4.82 - $6.93 $259,846 - $373,596	53,910 Added 187.55%	82,655 $429,000
Q4 2023 Feb 01, 2024	SELL	$5.63 - $8.27 $171,771 - $252,317	-30,510 Reduced 51.49%	28,745 $194,000
Q3 2023 Nov 06, 2023	BUY	$6.71 - $11.83 $62,973 - $111,024	9,385 Added 18.82%	59,255 $397,000
Q2 2023 Aug 01, 2023	BUY	$11.12 - $22.2 $8,629 - $17,227	776 Added 1.58%	49,870 $571,000
Q1 2023 May 05, 2023	BUY	$18.7 - $23.07 $7,386 - $9,112	395 Added 0.81%	49,094 $988,000
Q4 2022 Jan 24, 2023	BUY	$18.12 - $27.32 $2,718 - $4,098	150 Added 0.31%	48,699 $0
Q3 2022 Nov 10, 2022	BUY	$16.98 - $25.54 $4,092 - $6,155	241 Added 0.5%	48,549 $911,000
Q2 2022 Aug 11, 2022	BUY	$13.15 - $20.45 $100,360 - $156,074	7,632 Added 18.76%	48,308 $900,000
Q1 2022 Apr 20, 2022	BUY	$14.54 - $21.5 $20,123 - $29,756	1,384 Added 3.52%	40,676 $735,000
Q4 2021 Feb 02, 2022	BUY	$20.24 - $36.01 $2,530 - $4,501	125 Added 0.32%	39,292 $815,000
Q3 2021 Oct 28, 2021	BUY	$26.01 - $38.22 $48,820 - $71,738	1,877 Added 5.03%	39,167 $1.25 Million
Q2 2021 Aug 13, 2021	BUY	$29.97 - $37.17 $48,671 - $60,364	1,624 Added 4.55%	37,290 $1.15 Million
Q1 2021 May 06, 2021	BUY	$29.24 - $42.03 $404,623 - $581,611	13,838 Added 63.4%	35,666 $1.2 Million
Q4 2020 Feb 09, 2021	BUY	$35.35 - $50.67 $91,556 - $131,235	2,590 Added 13.46%	21,828 $789,000
Q3 2020 Nov 03, 2020	BUY	$35.98 - $47.66 $207,244 - $274,521	5,760 Added 42.74%	19,238 $709,000
Q2 2020 Jul 31, 2020	BUY	$45.06 - $67.74 $1,712 - $2,574	38 Added 0.28%	13,478 $607,000
Q1 2020 May 01, 2020	SELL	$40.01 - $73.97 $10,202 - $18,862	-255 Reduced 1.86%	13,440 $638,000
Q4 2019 Feb 03, 2020	BUY	$37.13 - $74.62 $70,658 - $142,001	1,903 Added 16.14%	13,695 $981,000
Q3 2019 Nov 01, 2019	BUY	$39.36 - $76.8 $269,025 - $524,928	6,835 Added 137.89%	11,792 $464,000
Q2 2019 Aug 01, 2019	BUY	$52.76 - $82.19 $261,531 - $407,415	4,957 New	4,957 $387,000

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $270M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account

Sigma Planning Corp Uni Qure N.V. Transaction History